Study identifies two factors that may help patients benefit from off-the-shelf CAR T-cell therapies

Researchers at The University of Texas MD Anderson Cancer Center have traced how off-the-shelf chimeric antigen receptor (CAR) T cells behave in patients, revealing how immune rejection and differences among CAR T cells influence their ability to multiply after infusion.

≈